• Home
  • Our Team
  • About Us
  • Contact Us
Saturday, June 28, 2025
Jammu Kashmir News Service | JKNS
  • Home
  • Top Stories
  • Kashmir
  • Jammu
  • National
  • Business
  • Sports
  • Oped
  • World
No Result
View All Result
  • Home
  • Top Stories
  • Kashmir
  • Jammu
  • National
  • Business
  • Sports
  • Oped
  • World
No Result
View All Result
Jammu Kashmir News Service | JKNS
No Result
View All Result
Home National

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

JK News Service by JK News Service
August 10, 2022
in National, Top Stories
A A
FacebookTwitterWhatsapp

In a first, the government has approved Biological E’s Corbevax as a precautionary dose for those above 18 years fully vaccinated with either Covishield or Covaxin.

The government has approved Biological E’s Corbevax as a precautionary dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday.

This is the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.

The sources told PTI that the Union Health Ministry’s approval is based on the recommendations made recently by the COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI).

Previous Post

Delhi schools step up measures amid rise in Covid-19 cases

Next Post

Inter-ministerial Secretaries to finalise calendar for G20 meetings on August 17

Next Post

Inter-ministerial Secretaries to finalise calendar for G20 meetings on August 17

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Home
  • Our Team
  • About Us
  • Contact Us
Dalgate, Near C.D hospital Srinagar Jammu and Kashmir. Pincode: 190001.
Email us: [email protected]

© JKNS - Designed and Developed by GITS.

No Result
View All Result
  • Home
  • Top Stories
  • Kashmir
  • Jammu
  • National
  • Business
  • Sports
  • Oped
  • World

© JKNS - Designed and Developed by GITS.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.